Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -32.94M | -6587.8% | $ 500K |
3/31/2025 | $ -33.19M | 0% | $ 0 |
12/31/2024 | $ -32.83M | 0% | $ 0 |
6/30/2024 | $ -20.03M | -1837.45% | $ 1.09M |
12/31/2023 | $ -21.13M | -211.32% | $ 10M |
6/30/2023 | $ -42.02M | -471.56% | $ 8.91M |
12/31/2022 | $ -48.54M | 0% | $ 0 |
6/30/2022 | $ -43.12M | 0% | $ 0 |
12/31/2021 | $ -7.22M | -15.83% | $ 45.58M |
6/30/2021 | $ -9.2M | -20.17% | $ 45.58M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for MEREO BIOPHARMA GROUP PLC is calculated as follows: FCF [ $ -35.45M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |